Companies: 10,795·Total market cap: $144.5T
MediWound Ltd.

MediWound Ltd.

MDWDNASDAQHealthcare● Active
$14.32
+$0.14(+0.99%)
Market Cap$155550714
P/E Ratio
52W High$22.09
52W Low$13.54

MediWound Ltd. (MDWD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mdwd · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for MediWound Ltd. (MDWD) measures how much investors pay for each dollar of the company's trailing earnings. MDWD's current PE ratio of N/A is calculated by dividing its stock price of $14.32 by its TTM earnings per share of -$2.03.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-2.13
Based on 5 analysts
EPS (TTM)
-$2.03
TTM · diluted EPS
PEG Ratio
0.32
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MediWound Ltd. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2011 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 24.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
MediWound Ltd.
MediWound Ltd.You
MDWD
$156MN/A-$2.03
Aardvark Therapeutics, Inc. Common Stock
Aardvark Therapeutics, Inc. Common Stock
AARD
$79MN/A-$2.64
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc.
EPRX
$201MN/A-$1.35
Genfit S.A.
Genfit S.A.
GNFT
$446M119.75x$0.03
Inventiva S.A.
Inventiva S.A.
IVA
$202MN/A-$1.82
Invivyd, Inc.
Invivyd, Inc.
IVVD
$135MN/A-$0.30
Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc.
NTHI
$91MN/A-$3.23

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 15 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-2.10
2024-12-31
FY2024
$-3.03
2023-12-31
FY2023
$-0.75
2022-12-31
FY2022
$-3.93
2021-12-31
FY2021
$-3.48
2020-12-31
FY2020
$-2.37
2019-12-31
FY2019
17.01x$1.28
2018-12-31
FY2018
$-0.27
2017-12-31
FY2017
$-6.64
2016-12-31
FY2016
$-6.05

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for MediWound Ltd. (MDWD) measures how much investors pay for each dollar of the company's trailing earnings. MDWD's current PE ratio of N/A is calculated by dividing its stock price of $14.32 by its TTM earnings per share of -$2.03.

PE Ratio = Stock Price ÷ EPS (TTM)
= $14.32 ÷ -$2.03 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MDWD pe ratio · 6 questions

MDWD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $14.32 and TTM EPS of -$2.03. Data sourced from Financial Modeling Prep via MDWD's SEC 10-K and 10-Q filings.

MDWD PE ratioWhat is MDWD PE ratioCurrent PE ratio of MDWDMDWD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MediWound Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08